Key statistics
As of last trade United Therapeutics Corp (UTHR*:MEX) traded at 6,902.22, 0.00% below its 52-week high of 6,902.22, set on Oct 09, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 6,902.22 |
---|---|
High | 6,902.22 |
Low | 6,902.22 |
Bid | -- |
Offer | -- |
Previous close | 6,902.22 |
Average volume | -- |
---|---|
Shares outstanding | 44.64m |
Free float | 43.82m |
P/E (TTM) | 16.15 |
Market cap | 16.40bn USD |
EPS (TTM) | 22.75 USD |
Data delayed at least 20 minutes, as of Oct 09 2024 12:30 BST.
More ▼
Press releases
- United Therapeutics Corporation to Present at the UBS Global Healthcare Conference
- United Therapeutics Corporation Reports Third Quarter 2024 Financial Results
- United Therapeutics Corporation Announces the 500th Lung Transplant Utilizing its Centralized Ex Vivo Lung Perfusion Service
- United Therapeutics Corporation to Report Third Quarter 2024 Financial Results Before the Market Opens on Wednesday, October 30, 2024
- United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the CHEST 2024 Annual Meeting
- United Therapeutics Publishes its 2024 Corporate Responsibility and Public Benefit Report Highlighting its Progress Toward a Future Where No Patient Gets Left Behind—Ever
- United Therapeutics Corporation to Present at Upcoming Investor Conferences
More ▼